GlassScriptPhysician profile
Julie Gail Sullivan
NPI 1578568010
$2,037.22
in general payments reported to CMS, 2019-2025
20 companies · $343 in 2025
The $343 reported for 2025 was more than what 86% of Adolescent Medicine (Pediatrics) providers received nationally (typical 2025 total: $99.31).
See the full distribution for Adolescent Medicine (Pediatrics)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $79.38 · 2020: $99.06 · 2021: $397 · 2022: $296 · 2023: $488 · 2024: $334 · 2025: $343.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,165.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,165.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $487.70 | 2022-2025 | Azstarys |
| Pfizer INC. | $220.17 | 2020-2023 | |
| Ironshore Pharmaceuticals INC. | $199.44 | 2019-2024 | Jornay Pm |
| Takeda Pharmaceuticals U.S.A., INC. | $198.44 | 2019-2022 | |
| Supernus Pharmaceuticals, INC. | $170.12 | 2021-2023 | Qelbree |
| Merck Sharp & Dohme LLC | $145.18 | 2021-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Tris Pharma INC | $106.90 | 2021-2024 | Dyanavel Xr |
| Kowa Pharmaceuticals America, INC. | $66.89 | 2025 | Zoryve |
| Sobi, INC | $66.84 | 2019-2023 | |
| Sanofi Pasteur INC. | $57.14 | 2020-2022 | |
| Collegium Pharmaceutical, INC. | $56.10 | 2025 | Jornay Pm |
| Vertical Pharmaceuticals, LLC | $49.53 | 2025 | Relexxii |
| Seqirus USA INC | $46.96 | 2022-2025 | Flucelvax, Flucelvax Quadrivalent |
| Biogen, INC. | $34.68 | 2024-2025 | Skyclarys |
| Glaxosmithkline, LLC. | $29.15 | 2020-2023 | Bexsero |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ars Pharmaceuticals Operations, INC. | $23.95 | 2025 | Neffy |
| Kaleo, INC. | $23.27 | 2020-2021 | |
| Shire North American Group INC | $22.68 | 2019 | |
| Alk-Abello, INC | $19.72 | 2023 | Grastek, Odactra, Ragwitek |
| Arbor Pharmaceuticals, INC. | $12.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julie Sullivan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.